Article Versions Notes

Alshammari RA, Aleanizy FS, Aldarwesh A, Alqahtani FY, Mahdi WA, Alquadeib B, Alqahtani QH, Haq N, Shakeel F, Abdelhady HG, et al. Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers. Pharmaceutics. 2022; 14(7):1444. https://doi.org/10.3390/pharmaceutics14071444

Alshammari, Rehab A., Fadilah S. Aleanizy, Amal Aldarwesh, Fulwah Y. Alqahtani, Wael A. Mahdi, Bushra Alquadeib, Qamraa H. Alqahtani, Nazrul Haq, Faiyaz Shakeel, Hosam G. Abdelhady, and et al. 2022. "Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers" Pharmaceutics 14, no. 7: 1444. https://doi.org/10.3390/pharmaceutics14071444

Alshammari, R. A., Aleanizy, F. S., Aldarwesh, A., Alqahtani, F. Y., Mahdi, W. A., Alquadeib, B., Alqahtani, Q. H., Haq, N., Shakeel, F., Abdelhady, H. G., & Alsarra, I. A. (2022). Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers. Pharmaceutics, 14(7), 1444. https://doi.org/10.3390/pharmaceutics14071444